Evaluation of Efficacy of Mirtazapine on Pruritus and Serum Histamine and Serotonin Levels in Patients Undergoing Hemodialysis: A Before–After Pilot Clinical Trial

References

• Pisoni RL, Wikström B, Elder SJ, et al. Pruritus in haemodialysis patients: international results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant. 2006;21(12):3495–3505. doi:10.1093/ndt/gfl46116968725
   PubMed Web of Science ®Google Scholar
• Mettang T, Kremer AE. Uremic pruritus. Kidney Int. 2015;87(4):685–691. doi:10.1038/ki.2013.45424402092
   PubMed Web of Science ®Google Scholar
• Shirazian S, Aina O, Park Y, et al. Chronic kidney disease-associated pruritus: impact on quality of life and current management challenges. Int J Nephrol Renovasc Dis. 2017;10:11. doi:10.2147/IJNRD.S10804528176969
   PubMed Web of Science ®Google Scholar
• Simonsen E, Komenda P, Lerner B, et al. Treatment of uremic pruritus: a systematic review. Am J Kidney Dis. 2017;70(5):638–655. doi:10.1053/j.ajkd.2017.05.01828720208
   PubMed Web of Science ®Google Scholar
• Narita I, Alchi B, Omori K, et al. Etiology and prognostic significance of severe uremic pruritus in chronic hemodialysis patients. Kidney Int. 2006;69(9):1626–1632. doi:10.1038/sj.ki.500025116672924
   PubMed Web of Science ®Google Scholar
• Weisbord SD, Fried LF, Mor MK, et al. Renal provider recognition of symptoms in patients on maintenance hemodialysis. Clin J Am Soc Nephrol. 2007;2(5):960–967. doi:10.2215/CJN.0099020717702730
   PubMed Web of Science ®Google Scholar
• Weisshaar E, Matterne U, Mettang T. How do nephrologists in haemodialysis units consider the symptom of itch? Results of a survey in Germany. Nephrol Dial Transplant. 2009;24(4):1328–1330. doi:10.1093/ndt/gfn76919155533
   PubMed Web of Science ®Google Scholar
• Lugon JR. Uremic pruritus: a review. Hemodial Int. 2005;9(2):180–188. doi:10.1111/j.1492-7535.2005.01130.x16191067
   PubMedGoogle Scholar
• Grundmann S, Ständer S. Chronic pruritus: clinics and treatment. Ann Dermatol. 2011;23(1):1–11. doi:10.5021/ad.2011.23.1.121738356
   PubMed Web of Science ®Google Scholar
• Stockenhuber F, Kurz RW, Sertl K, Grimm G, Balcke P. Increased plasma histamine levels in uraemic pruritus. Clin Sci. 1990;79(5):477–482. doi:10.1042/cs07904772174315
   PubMed Web of Science ®Google Scholar
• Mysliwiec H, Pawlak D, Serwin A, Mysliwiec P, Mysliwiec M, Chodynicka B. The role of serotonin and tryptophan in uremic pruritus in hemodialysed patients. Przegl Dermatol. 2006;93(1):61.
   Google Scholar
• Balaskas EV, Bamihas GI, Karamouzis M, Voyiatzis G, Tourkantonis A. Histamine and serotonin in uremic pruritus: effect of ondansetron in CAPD-pruritic patients. Nephron. 1998;78(4):395–402. doi:10.1159/0000449679578065
   PubMed Web of Science ®Google Scholar
• Schwörer H, Ramadori G. Treatment of pruritus: a new indication for serotonin type 3 receptor antagonists. Clin Investig. 1993;71(8):659–662. doi:10.1007/BF00184497
   Google Scholar
• Anttila SA, Leinonen EV. A review of the pharmacological and clinical profile of mirtazapine. CNS Drug Rev. 2001;7(3):249–264. doi:10.1111/j.1527-3458.2001.tb00198.x11607047
   PubMedGoogle Scholar
• Alam A, Voronovich Z, Carley JA. A review of therapeutic uses of mirtazapine in psychiatric and medical conditions. Prim Care Companion CNS Disord. 2013;15(5).
   Google Scholar
• Khanna R, Boozalis E, Belzberg M, Zampella JG, Kwatra SG. Mirtazapine for the treatment of chronic pruritus. Medicines. 2019;6(3):73. doi:10.3390/medicines6030073
   Google Scholar
• Kulaç M, Karaca Ş, Özbulut Ö, Çetişli A. Oral mirtazapine in persistent chronic urticaria. TURKDERM-Arch Turkish Dermatol Venerol. 2008;42(1):31–33.
   Web of Science ®Google Scholar
• Lee JJ, Girouard SD, Carlberg VM, Mostaghimi A. Effective use of mirtazapine for refractory pruritus associated with carcinoma en cuirasse. BMJ Support Palliat Care. 2016;6(1):119–121. doi:10.1136/bmjspcare-2014-000790
   PubMed Web of Science ®Google Scholar
• Demierre M-F, Taverna J. Mirtazapine and gabapentin for reducing pruritus in cutaneous T-cell lymphoma. J Am Acad Dermatol. 2006;55(3):543–544. doi:10.1016/j.jaad.2006.04.02516908377
   PubMed Web of Science ®Google Scholar
• Gill D, Fonseca V, Barradas M, Balliod R, Moorhead J, Dandona P. Plasma histamine in patients with chronic renal failure and nephrotic syndrome. J Clin Pathol. 1991;44(3):243–245. doi:10.1136/jcp.44.3.2432013627
   PubMed Web of Science ®Google Scholar
• Eyler RF, Unruh ML, Quinn DK, Mary Vilay A. Psychotherapeutic agents in end‐stage renal disease. Semin Dial. 2015 ;28(4):417-426
   Google Scholar
• Nagler EV, Webster AC, Vanholder R, Zoccali C. Antidepressants for depression in stage 3–5 chronic kidney disease: a systematic review of pharmacokinetics, efficacy and safety with recommendations by European Renal Best Practice (ERBP). Nephrol Dial Transplant. 2012;27(10):3736–3745. doi:10.1093/ndt/gfs29522859791
   PubMed Web of Science ®Google Scholar
• Reich A, Heisig M, Phan NQ, et al. Visual analogue scale: evaluation of the instrument for the assessment of pruritus. Acta Derm Venereol. 2012;92(5):497–501. doi:10.2340/00015555-126522102095
   PubMed Web of Science ®Google Scholar
• Takahashi N, Yoshizawa T, Kumagai J, et al. Response of patients with hemodialysis-associated pruritus to new treatment algorithm with nalfurafine hydrochloride: a retrospective survey-based study. Ren Replace Ther. 2016;2(1):27. doi:10.1186/s41100-016-0039-x
   Google Scholar
• Feramisco JD, Berger TG, Steinhoff M. Innovative management of pruritus. Dermatol Clin. 2010;28(3):467–478. doi:10.1016/j.det.2010.03.00420510757
   PubMed Web of Science ®Google Scholar
• Kremer AE, Elferink RPO, Beuers U. Pathophysiology and current management of pruritus in liver disease. Clin Res Hepatol Gastroenterol. 2011;35(2):89–97. doi:10.1016/j.clinre.2010.10.00721809485
   PubMed Web of Science ®Google Scholar
• El-Nour H, Lundeberg L, Abdel-Magid N, Lonne-Rahm S-B, C Azmitia E, Nordlind K. Serotonergic mechanisms in human allergic contact dermatitis. Acta Derm Venereol. 2007;87(5):390–396. doi:10.2340/00015555-028817721644
   PubMed Web of Science ®Google Scholar
• Lonne‐Rahm SB, Rickberg H, El‐Nour H, Mårin P, Azmitia E, Nordlind K. Neuroimmune mechanisms in patients with atopic dermatitis during chronic stress. J Eur Acad Dermatol Venereol. 2008;22(1):11–18. doi:10.1111/j.1468-3083.2007.02202.x18181968
   PubMed Web of Science ®Google Scholar
• Manenti L, Tansinda P, Vaglio A. Uraemic pruritus. Drugs. 2009;69(3):251–263. doi:10.2165/00003495-200969030-0000219275270
   PubMed Web of Science ®Google Scholar
• Charuluxananan S, Kyokong O, Somboonviboon W, Narasethakamol A, Promlok P. Nalbuphine versus ondansetron for prevention of intrathecal morphine-induced pruritus after cesarean delivery. Anesth Analg. 2003;96(6):1789–1793. doi:10.1213/01.ANE.0000066015.21364.7D12761013
   PubMed Web of Science ®Google Scholar
• Parada C, Tambeli C, Cunha F, Ferreira S. The major role of peripheral release of histamine and 5-hydroxytryptamine in formalin-induced nociception. Neuroscience. 2001;102(4):937–944. doi:10.1016/S0306-4522(00)00523-611182255
   PubMed Web of Science ®Google Scholar
• Umeuchi H, Togashi Y, Honda T, et al. Involvement of central μ-opioid system in the scratching behavior in mice, and the suppression of it by the activation of κ-opioid system. Eur J Pharmacol. 2003;477(1):29–35. doi:10.1016/j.ejphar.2003.08.00714512095
   PubMed Web of Science ®Google Scholar
• Croom KF, Perry CM, Plosker GL. Mirtazapine. CNS Drugs. 2009;23(5):427–452. doi:10.2165/00023210-200923050-0000619453203
   PubMed Web of Science ®Google Scholar
• Davis MP, Frandsen JL, Walsh D, Andresen S, Taylor S. Mirtazapine for pruritus. J Pain Symptom Manage. 2003;25(3):288–291. doi:10.1016/S0885-3924(02)00645-012614964
   PubMed Web of Science ®Google Scholar
• Hundley JL, Yosipovitch G. Mirtazapine for reducing nocturnal itch in patients with chronic pruritus: a pilot study. J Am Acad Dermatol. 2004;50(6):889–891. doi:10.1016/j.jaad.2004.01.04515153889
   PubMed Web of Science ®Google Scholar
• Alhashemi JA, Crosby ET, Grodecki W, Duffy PJ, Hull KA, Gallant C. Treatment of intrathecal morphine-induced pruritus following caesarean section. Can J Anaesth. 1997;44(10):1060. doi:10.1007/BF030192279350364
   PubMed Web of Science ®Google Scholar
• Weisshaar E, Ziethen B, Röhl FW, Gollnick H. The antipruritic effect of a 5‐HT3 receptor antagonist (tropisetron) is dependent on mast cell depletion–an experimental study. Exp Dermatol. 1999;8(4):254–260. doi:10.1111/j.1600-0625.1999.tb00379.x10439222
   PubMed Web of Science ®Google Scholar
• Chavkin C. The therapeutic potential of κ-opioids for treatment of pain and addiction. Neuropsychopharmacology. 2011;36(1):369. doi:10.1038/npp.2010.13721116263
   PubMed Web of Science ®Google Scholar
• Wikström B, Gellert R, Ladefoged SD, et al. κ-Opioid system in uremic pruritus: multicenter, randomized, double-blind, placebo-controlled clinical studies. Clin J Am Soc Nephrol. 2005;16(12):3742–3747. doi:10.1681/ASN.2005020152
   Web of Science ®Google Scholar
• Schreiber S, Rigai T, Katz Y, Pick CG. The antinociceptive effect of mirtazapine in mice is mediated through serotonergic, noradrenergic and opioid mechanisms. Brain Res Bull. 2002;58(6):601–605. doi:10.1016/S0361-9230(02)00825-012372565
   PubMed Web of Science ®Google Scholar
• Montgomery S. Safety of mirtazapine: a review. Int Clin Psychopharmacol. 1995;10(Supplement 4):37–45. doi:10.1097/00004850-199512004-00006
   Web of Science ®Google Scholar
• Bossola M, Tazza L, Giungi S, Luciani G. Anorexia in hemodialysis patients: an update. Kidney Int. 2006;70(3):417–422. doi:10.1038/sj.ki.500157216775598
   PubMed Web of Science ®Google Scholar
• Evans PD, Taal MW. Epidemiology and causes of chronic kidney disease. Medicine. 2015;43(8):450–453. doi:10.1016/j.mpmed.2015.05.005
   Google Scholar
• Park J, Lertdumrongluk P, Molnar MZ, Kovesdy CP, Kalantar-Zadeh K. Glycemic control in diabetic dialysis patients and the burnt-out diabetes phenomenon. Curr Diab Rep. 2012;12(4):432–439. doi:10.1007/s11892-012-0286-322638938
   PubMed Web of Science ®Google Scholar
• Song HR, Woo YS, Wang H-R, Shim I-H, Jun T-Y, Bahk W-M. Does mirtazapine interfere with naturalistic diabetes treatment? J Clin Psychopharmacol. 2014;34(5):588–594. doi:10.1097/JCP.000000000000018324987796
   PubMed Web of Science ®Google Scholar
• Himmerich H, Fulda S, Schaaf L, Beitinger PA, Schuld A, Pollmacher T. Changes in weight and glucose tolerance during treatment with mirtazapine. Diabetes Care. 2006;29(1):170–171. doi:10.2337/diacare.29.01.06.dc05-1762
   PubMed Web of Science ®Google Scholar
• Asgari MR, Asghari F, Ghods AA, Ghorbani R, Motlagh NH, Rahaei F. Incidence and severity of nausea and vomiting in a group of maintenance hemodialysis patients. J Renal Inj Prev. 2017;6(1):49. doi:10.15171/jrip.2017.0928487872
   PubMed Web of Science ®Google Scholar
• Violani C, Lucidi F, Devoto A, Lombardo C, De Santo RM. Insomnia and its comorbidities in chronic kidney disease. Semin Nephrol. 2006; 26:61–63.
   Web of Science ®Google Scholar
• Pham PC, Khaing K, Sievers TM, et al. 2017 update on pain management in patients with chronic kidney disease. Clin Kidney J. 2017;10(5):688–697. doi:10.1093/ckj/sfx08028979781
   PubMed Web of Science ®Google Scholar
• Zhu J, Wei X, Feng X, Song J, Hu Y, Xu J. Repeated administration of mirtazapine inhibits development of hyperalgesia/allodynia and activation of NF-κB in a rat model of neuropathic pain. Neurosci Lett. 2008;433(1):33–37. doi:10.1016/j.neulet.2007.12.03718248895
   PubMed Web of Science ®Google Scholar
• Theobald DE, Kirsh KL, Holtsclaw E, Donaghy K, Passik SD. An open-label, crossover trial of mirtazapine (15 and 30 mg) in cancer patients with pain and other distressing symptoms. J Pain Symptom Manage. 2002;23(5):442–447. doi:10.1016/S0885-3924(02)00381-012007762
   PubMed Web of Science ®Google Scholar
• Rama M, Viswanathan G, Acharya LD, Attur R, Reddy P, Raghavan S. Assessment of drug-drug interactions among renal failure patients of nephrology ward in a South Indian tertiary care hospital. Indian J Pharm Sci. 2012;74(1):63. doi:10.4103/0250-474X.10254523204624
   PubMed Web of Science ®Google Scholar
• Soldatos CR, Dikeos DG, Paparrigopoulos TJ. Athens insomnia scale: validation of an instrument based on ICD-10 criteria. J Psychosom Res. 2000;48(6):555–560. doi:10.1016/S0022-3999(00)00095-711033374
   PubMed Web of Science ®Google Scholar
• Buysse DJ, Reynolds III CF, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh sleep quality index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28(2):193–213. doi:10.1016/0165-1781(89)90047-42748771
   PubMed Web of Science ®Google Scholar